229 related articles for article (PubMed ID: 9256476)
1. Thymocyte development is normal in CTLA-4-deficient mice.
Chambers CA; Cado D; Truong T; Allison JP
Proc Natl Acad Sci U S A; 1997 Aug; 94(17):9296-301. PubMed ID: 9256476
[TBL] [Abstract][Full Text] [Related]
2. Lymphoproliferation in CTLA-4-deficient mice is mediated by costimulation-dependent activation of CD4+ T cells.
Chambers CA; Sullivan TJ; Allison JP
Immunity; 1997 Dec; 7(6):885-95. PubMed ID: 9430233
[TBL] [Abstract][Full Text] [Related]
3. Cytotoxic T lymphocyte antigen-4 (CTLA-4) regulates primary and secondary peptide-specific CD4(+) T cell responses.
Chambers CA; Kuhns MS; Allison JP
Proc Natl Acad Sci U S A; 1999 Jul; 96(15):8603-8. PubMed ID: 10411922
[TBL] [Abstract][Full Text] [Related]
4. The role of B7 costimulation in CD4/CD8 T cell homeostasis.
Yu X; Fournier S; Allison JP; Sharpe AH; Hodes RJ
J Immunol; 2000 Apr; 164(7):3543-53. PubMed ID: 10725709
[TBL] [Abstract][Full Text] [Related]
5. Secondary but not primary T cell responses are enhanced in CTLA-4-deficient CD8+ T cells.
Chambers CA; Sullivan TJ; Truong T; Allison JP
Eur J Immunol; 1998 Oct; 28(10):3137-43. PubMed ID: 9808182
[TBL] [Abstract][Full Text] [Related]
6. Blockade of T cell activation using a surface-linked single-chain antibody to CTLA-4 (CD152).
Griffin MD; Hong DK; Holman PO; Lee KM; Whitters MJ; O'Herrin SM; Fallarino F; Collins M; Segal DM; Gajewski TF; Kranz DM; Bluestone JA
J Immunol; 2000 May; 164(9):4433-42. PubMed ID: 10779742
[TBL] [Abstract][Full Text] [Related]
7. Role of CTLA-4 in the activation of single- and double-positive thymocytes.
Kwon H; Jun HS; Khil LY; Yoon JW
J Immunol; 2004 Dec; 173(11):6645-53. PubMed ID: 15557155
[TBL] [Abstract][Full Text] [Related]
8. CTLA-4 blockade reverses CD8+ T cell tolerance to tumor by a CD4+ T cell- and IL-2-dependent mechanism.
Shrikant P; Khoruts A; Mescher MF
Immunity; 1999 Oct; 11(4):483-93. PubMed ID: 10549630
[TBL] [Abstract][Full Text] [Related]
9. Rescue of thymocytes from glucocorticoid-induced cell death mediated by CD28/CTLA-4 costimulatory interactions with B7-1/B7-2.
Wagner DH; Hagman J; Linsley PS; Hodsdon W; Freed JH; Newell MK
J Exp Med; 1996 Nov; 184(5):1631-8. PubMed ID: 8920853
[TBL] [Abstract][Full Text] [Related]
10. Cytotoxic T lymphocyte-associated antigen 4 (CTLA-4) can regulate dendritic cell-induced activation and cytotoxicity of CD8(+) T cells independently of CD4(+) T cell help.
McCoy KD; Hermans IF; Fraser JH; Le Gros G; Ronchese F
J Exp Med; 1999 Apr; 189(7):1157-62. PubMed ID: 10190907
[TBL] [Abstract][Full Text] [Related]
11. CTLA-4 and T cell activation.
Oosterwegel MA; Greenwald RJ; Mandelbrot DA; Lorsbach RB; Sharpe AH
Curr Opin Immunol; 1999 Jun; 11(3):294-300. PubMed ID: 10375557
[TBL] [Abstract][Full Text] [Related]
12. B7-1 or B7-2 is required to produce the lymphoproliferative phenotype in mice lacking cytotoxic T lymphocyte-associated antigen 4 (CTLA-4).
Mandelbrot DA; McAdam AJ; Sharpe AH
J Exp Med; 1999 Jan; 189(2):435-40. PubMed ID: 9892625
[TBL] [Abstract][Full Text] [Related]
13. Lymphoproliferative disorder in CTLA-4 knockout mice is characterized by CD28-regulated activation of Th2 responses.
Khattri R; Auger JA; Griffin MD; Sharpe AH; Bluestone JA
J Immunol; 1999 May; 162(10):5784-91. PubMed ID: 10229811
[TBL] [Abstract][Full Text] [Related]
14. Absence of CTLA-4 lowers the activation threshold of primed CD8+ TCR-transgenic T cells: lack of correlation with Src homology domain 2-containing protein tyrosine phosphatase.
Gajewski TF; Fallarino F; Fields PE; Rivas F; Alegre ML
J Immunol; 2001 Mar; 166(6):3900-7. PubMed ID: 11238634
[TBL] [Abstract][Full Text] [Related]
15. CTLA-4 regulates tolerance induction and T cell differentiation in vivo.
Walunas TL; Bluestone JA
J Immunol; 1998 Apr; 160(8):3855-60. PubMed ID: 9558090
[TBL] [Abstract][Full Text] [Related]
16. Cutting edge: CTLA-4 (CD152) differentially regulates mitogen-activated protein kinases (extracellular signal-regulated kinase and c-Jun N-terminal kinase) in CD4+ T cells from receptor/ligand-deficient mice.
Schneider H; Mandelbrot DA; Greenwald RJ; Ng F; Lechler R; Sharpe AH; Rudd CE
J Immunol; 2002 Oct; 169(7):3475-9. PubMed ID: 12244135
[TBL] [Abstract][Full Text] [Related]
17. The lymphoproliferative defect in CTLA-4-deficient mice is ameliorated by an inhibitory NK cell receptor.
Chambers CA; Kang J; Wu Y; Held W; Raulet DH; Allison JP
Blood; 2002 Jun; 99(12):4509-16. PubMed ID: 12036882
[TBL] [Abstract][Full Text] [Related]
18. Cutting edge: lymphoproliferative disease in the absence of CTLA-4 is not T cell autonomous.
Bachmann MF; Köhler G; Ecabert B; Mak TW; Kopf M
J Immunol; 1999 Aug; 163(3):1128-31. PubMed ID: 10415006
[TBL] [Abstract][Full Text] [Related]
19. CD28 and CTLA-4 have opposing effects on the response of T cells to stimulation.
Krummel MF; Allison JP
J Exp Med; 1995 Aug; 182(2):459-65. PubMed ID: 7543139
[TBL] [Abstract][Full Text] [Related]
20. Enhanced expression of CTLA-4 (CD152) on CD4+ T cells in HIV infection.
Steiner K; Waase I; Rau T; Dietrich M; Fleischer B; Bröker BM
Clin Exp Immunol; 1999 Mar; 115(3):451-7. PubMed ID: 10193417
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
